including ThioBridge™ for more stable and homogeneous antibody drug conjugates, TheraPEG™, CyPEG™, HiPEG™ and PolyPEG™ for optimisation of the pharmacokinetics of biologics and GlycoPol™ for targeted delivery.
The PolyTherics group will provide immunogenicity testing, antibody humanisation and protein re-engineering technologies through its Antitope subsidiary, including EpiScreen™, Composite Human Antibody™, Composite Protein™ and Composite CHO™. These technologies have been used to develop several therapeutic antibody candidates that are advancing through clinical trials. The group provides its services and technologies to an international client base that includes many of the world's leading biotechnology and pharmaceutical companies.
PolyTherics is a privately owned UK company backed by institutional investors including Imperial Innovations (AIM: IVO), Invesco Perpetual, Mercia Fund Management, Advantage Enterprise & Innovation Fund (managed by Catapult Venture Partners), ProVen Health, Oxford Technology VCTs and high net worth individual's funds managed by Longbow Capital. The Company has dedicated facilities in London, Cambridge and Coventry, UK.
For more information contact:
John Burt, PolyTherics
Matthew Baker, Antitope
Mark Swallow, Sita Shah, Chris GardnerPage: 1 2 3 4 Related biology technology :1
. Shimadzu's New MALDI-7090 TOF-TOF Mass Spectrometer Combines High Throughput, High Resolution and High Energy for the Ultimate in Tandem MS Capabilities2
. FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice3
. Fantastic flash memory combines graphene and molybdenite4
. Motus Brings a Whole New Dimension to the NFL Combine Training Program at IMG Academy5
. New Informatics and Bioimaging Center combines resources, expertise from UMD, UMB6
. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May7
. QIAGEN Partners with Exosome Diagnostics to Create High-Performance Biofluid Sample Preparation Kits for Personalized Healthcare Research8
. NYSCF scientists create personalized bone substitutes from skin cells9
. American Management Association Teams With Biogen Idec To Create Life Skills Workshops For People Living With Hemophilia10
. Data Spectacles Create Rosy Tint11
. Leading Biotoxin & Mold Illness Authority Creates Certification Process for Treatment Protocol